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Prostaglandins protect kidneys against ischemic and toxic
injury by a cellular effect
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Prostaglandins protect kidneys against ischemic and toxic injury by a
celluJar effect. The ability of prostaglandins to protect the kidney against
ischemic and toxic renal injury was evaluated by in viva and in vitro
models of renal ischemia. The prostaglandin E1 analogue, misoprostol,
was found to provide significant protection against ischemia-induced
renal dysfunction in rats subjected to 40 minutes of renal artery
occlusion. Misoprostol-treated rats had glomerular filtration rates al-
most threefold greater than control animals, although renal blood flow
and renal vascular resistance were not significantly different. Improved
tubular function was reflected in a lower fractional excretion of sodium
and a higher urine-to-plasma creatinine ratio. Misoprostol also provided
similar protection in a model of toxic renal injury produced by mercuric
chloride. In an in vitro model employing primary cultures of proximal
tubule epithelial cells subjected to hypoxia and reoxygenation, miso-
prostol limited cell death. Posthypoxic cells had apical membrane
disruption and loss of microvilli when examined by transmission
electron microscopy. These changes were not seen in misoprostol-
treated cells. The "cytoprotective" effect was also produced by pros-
taglandin E2 and prostacyclin. The ability of prostaglandin E to protect
against toxic and ischemic renal injury did not appear to be due to an
antioxidant effect because misoprostol did not limit lipid peroxidation in
vivo and did not protect against oxidant injury by tert-butyl hydroper-
oxide in vitro. Although the exact mechanism of prostaglandin protec-
tion was not revealed, these studies demonstrate that prostaglandins
protect renal tubule epithelial cells from hypoxic injury at the cellular
level independent of hemodynamic factors or inflammatory responses.
Such a "cytoprotective" effect of prostaglandins may be a generalized
phenomenon since it has also been demonstrated in gastrointestinal
epithelium.
Prostaglandins have numerous renal effects on hemodynam-
ics, ion transport, and metabolism [1]. In addition, several
investigators have reported beneficial actions of prostaglandin
E or prostacyclin to limit ischemic or toxic renal injury [2—151.
In some studies prostaglandins increased both renal blood flow
(RBF) and glomerular filtration rate (GFR), suggesting that the
increase in RBF was responsible for the improved GFR.
However, in other studies, exogenous prostaglandins improved
GFR without an effect on RBF, suggesting a possible non-
hemodynamic action of prostaglandins to limit injury. Because
acute renal failure remains an important cause of patient
morbidity and mortality, the search for effective agents to
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prevent or attenuate injury or to enhance recovery from acute
renal insult continues.
Other cell types can also be protected by prostaglandins
against noxious stimuli. Gastric mucosa is the best studied
model. Exogenous prostaglandins protect gastric mucosa
against injury produced by aspirin, ethanol, and bile salts
[16—201. This protection has been termed "cytoprotection" to
imply a beneficial effect localized to the cell, independent of
changes in organ blood flow. The precise mechanism of cyto-
protection remains to be defined.
The purpose of the present study was to elucidate the
beneficial effects of a prostaglandin E1 analogue in two in vivo
models of acute renal injury: ischemia and mercuric chloride
administration. We subsequently sought to determine whether
these beneficial effects could be demonstrated in an in vitro
model of hypoxic injury so that hemodynamic and other factors
could be eliminated. Such a finding would indicate cytoprotec-
tion of renal epithelial cells by prostaglandins.
Methods
Ischemic acute renal ftiilure
Male Sprague-Dawley rats (Harlan, Madison, Wisconsin,
USA) weighing 225 to 290 g were allowed free access to food
and water until the time of study. Rats were anesthetized with
sodium pentobarbital (60 mg/kg i.p.) and an orogastric tube
(PE-100) was temporarily placed for administration of drugs.
The PGEJ analogue misoprostol ([± lmethyl[ 11 a, 13E]- 11, 16-dihy-
droxy-1 6-methyl-9-oxoprost- 13-en-I -oate; provided by Searle Re-
search and Development, Skokie, Illinois, USA) was initially
dissolved in absolute ethanol and then diluted in sodium phos-
phate buffer to yield a solution containing 200 g/ml. Control
animals received 0.5 ml of the ethanol/phosphate buffer via the
orogastric tube and experimental animals received misoprostol
333 j.g/kg. Thirty minutes later, a midline abdominal incision
was made and the right kidney was removed. The left kidney
was exposed, the perirenal fat removed, and the left renal artery
exposed. A non-traumatic vascular clamp was then placed
across the renal artery for 40 minutes. After removal of the
clamp, the animal was prepared for clearance studies. In other
animals bilateral flank incisions were made to expose the
kidneys. Right nephrectomy and left renal artery occlusion
were performed as described. After removal of the renal artery
clamp, the animals were sutured and allowed to recover for 24
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hours for clearance studies as described below. In a third group
of animals the effect of multiple preischemic doses of misopros-
tol was tested. Animals received misoprostol (or buffer) at 0800
and 1800 on the day before ischemia as well as 30 minutes
before ischemia. In these animals renal function was measured
24 hours after ischemia.
The effects of renal ischemia on renal function were assessed
by measurement of inulin clearance (GFR) and inulin extraction
to calculate renal blood flow. Animals were placed on a heated,
temperature-controlled table and a 23-gauge needle was also
inserted into the renal vein and secured with cyanoacrylate. A
priming infusion of 10% inulin in saline was begun at 0.06
mI/mm for 15 minutes, followed by a sustaining infusion of 0.02
mI/mm for the duration of the study, After a 60-minute equili-
bration period, three 20-minute urine collections were made.
Blood was obtained at the midpoint of each collection from the
femoral artery and renal vein for plasma inulin determination.
The concentration of inulin in urine and plasma was determined
by the anthrone method and inulin clearance and renal plasma
flow were calculated by the standard formulae. Renal blood
flow was calculated from renal plasma flow and hematocrit by
the standard formula.
Lipid peroxidation was measured after 40 minutes of isch-
emia plus 15 minutes of reperfusion, a time of maximum lipid
peroxidation [21] by determining the renal cortical content of
the lipid peroxidation product malondialdehyde (MDA) in a
separate group of animals. MDA was measured by the method
of Ohkawa, Ohishi and Yagi [221. After ischemia plus reperfu-
sion kidneys were rapidly removed and placed in iced phos-
phate buffered saline. Sections of renal cortex were suspended
in a total volume of 3 ml 100 mrvi KC1 plus 0.003 M EDTA and
homogenized with a Polytron (Brinkman Instruments, West-
bury, New York, USA) at setting 8 for 15 seconds. Homoge-
nates were then centrifuged at 600 g for 10 minutes. Two
hundred microliters of supernate were added to 0.2 ml 8.1%
sodium dodecyl sulfate, 1.5 ml 20% acetic acid (pH 3.5), 1.5 ml
0.8% thiobarbituric acid and 6.6 ml water. This solution was
heated to 95°C for 60 minutes. After addition of 1.0 ml water
and 5.0 ml of an n-butanol/pyridine mixture (15:1 vol/vol) the
mixture was vigorously shaken and centrifuged at 2000 g for 15
minutes. The absorbance of the upper organic layer at 532 nm
was determined in a spectrophotometer. Absorbance of tissue
samples was compared to results obtained using freshly pre-
pared malonaldehyde tetraethylacetal standards (Sigma Chem-
ical Co., St. Louis, Missouri, USA). MDA values were ex-
pressed per mg protein. All determinations of MDA were
performed in duplicate.
Mercuric chloride-induced acute renal failure
Rats were briefly anesthetized with ether and then given
misoprostol or buffer as described above. Thirty minutes later
each animal was given mercuric chloride (HgCl2) in a dose of 2
mg/kg subcutaneously as a 2.5 mg/mI 0.9% saline solution.
Twenty-four hours later the animals were prepared for clear-
ance studies and GFR and renal blood flow were measured as
above. In a second set of studies the dose of HgCI2 was
decreased to 1,5 mg/kg to reduce the amount of renal injury.
In vitro studies of hypoxic renal cell injury
Cell culture. Rat renal proximal tubule segments were iso-
lated by the method of Gesek, Wolff and Standhoy [231 which
employs collagenase digestion of the renal cortex followed by
Percoll density gradient centrifugation. This procedure yielded
a preparation primarily consisting of proximal tubule fragments
(>95%) with approximately 90% viability by vital dye exclu-
sion. Culture medium was RPM! 1640 containing amino acids
and vitamins, 11 mi glucose, 1 m Ca (NO3)2, 5.4 mM KCI, 0.4
mM MgS0, 103 mrvi NaCl, 5.6 mrvt Na2HPO4, 23.8 mM
NaHCO3, 10 mi Hepes, 10% fetal calf serum, 100 mU/mi
penicillin, and 100 mg/mI streptomycin to which 10 ng/ml
epidermal growth factor (EGF), 5 mg/mI transferrin, 5 mg/mi
insulin and 10_8 M dexamethasone (final concentrations) were
added. Tubule fragments were suspended in culture medium
and plated onto collagen gel-coated (Sigma, Type I) plastic
12-(4.5 cm2) multiwell plates. Culture medium was changed
every other day. Primary cultures were used for all studies. The
proximal origin of cultured cells was supported by preliminary
studies which showed expression of proximal tubule brush
border enzymes and formation of domes, evidence of vectorial
transport. Confluent monolayers were assayed in situ for the
brush border enzyme alkaline phosphatase using a cytochemi-
cal assay as described by Wachsmuth and Torhorst [24]. Cells
were fixed with formaldehyde-methanol and reacted with 0.33
mM naphthol AS-B! phosphate and 3 m fast red violet LB
(Sigma). Virtually 100% of cells showed staining for alkaline
phosphatase. Cells were also assayed for gamma-glutamyl-
transpeptidase activity, another proximal tubule brush border
marker, using L-gamma-glutamyl-3-carboxy-4-nitroanilide as
the substrate while spectrophotometrically monitoring the re-
action at 37°C [25]. Cell homogenates derived from sub-conflu-
ent monolayers contained 1.04 0.05 mol/min/mg protein of
the enzyme (N = 4), whereas fresh renal cortex had an enzyme
activity of 8.88 0.43 mol/min/mg protein.
Hypoxic cell injury. Cells were studied in a sub-confluent
stage, usually four days after initial plating. Forty-eight hours
before study the culture medium was switched to a glucose-free
formulation of the usual culture medium to enhance cell sus-
ceptibility to hypoxia/reoxygenation injury [26]. Two hours
before study, the medium was changed to glucose-free medium
without added growth factors. Cell plates were placed in an
airtight glass chamber under a continuous flow of humidified gas
and maintained at 37°C: hypoxia (95% N2, 5% C02) for 60
minutes followed by reoxygenation (95% 02, 5% C02) for 30
minutes. Cell injury was quantitated as the percent of total
cellular lactate dehydrogenase (LDH) released into the culture
medium. LDH was measured in the incubation medium and in
homogenized cells (Teflon-glass motorized mortar and pestle)
by monitoring the reduction of NAD in the presence of lactate
at 339 nm. The two values were summed to obtain total LDH.
To test the ability of misoprostol to protect against hypoxic
injury in vitro, misoprostol (10 to l0 M) was added to the
incubation medium two hours before the cells were subjected to
hypoxia and reoxygenation. In other studies either prostacy-
din, PGE2, or arachidonate were similarly prepared and added
to the incubation media prior to hypoxia.
The ability of misoprostol to protect against other causes of
E0
E
>
cell injury was tested by exposing cells to tert-butyl hydroper-
oxide, an oxidant whose effects on renal epithelial cells has
been well characterized F27, 28]. Cells were exposed to tert-
butyl hydroperoxide (2 to 10 mM) for 30 to 60 minutes without
or with concomitant addition of misoprostol.
Electron microscopy. Cells were grown on microporous cell
culture inserts (Falcon, Becton Dickinson Labware, Lincoln
Park, New Jersey, USA) to facilitate sectioning. Cells were
fixed in 2.5% phosphate-buffered glutaraldehyde for one hour,
and post-fixed in 1.5% buffered osmium tetroxide solution for
30 minutes. They were dehydrated in graded alcohol, trans-
ferred to acetone, and embedded in resin (Poly/Bed 812, Poly-
sciences, Inc., Warrington, Pennsylvania). Ultrathin sections
were mounted on a copper grid and stained with uranyl acetate
and lead citrate, and examined with a Philips 201 electron
microscope.
Results are reported as mean standard error. Intergroup
comparisons were made by Student's t-test for unpaired sam-
ples. When multiple comparisons were made the Bonferroni
method was used to determine the critical values for t. For
nonparametric data the Neuman-Keuls test was used.
Results
Ischemic renal injury
Pretreatment with misoprostol resulted in significant im-
provement in renal function whether measured one hour or 24
hours after ischemia. When animals were studied after one hour
of reperfusion, those that had received misoprostol tended to
have lower mean arterial pressure (90 8 vs. 102 7 mm Hg),
but this difference was not significant. As seen in Figure 1,
inulin clearance was higher in misoprostol-treated animals (0.34
0.07 vs. 0.12 0.02 mllmin) although renal blood flow and
renal vascular resistance were similar in control and misopros-
tol-treated animals. Better renal function in misoprostol-treated
animals was also reflected by a lower fractional excretion of
sodium (4.6 1.5 vs. 9.9 2.1; P < 0.05) and a higher
urine-to-plasma creatinine ratio (25.4 5.4 vs. 9.9 2.1; P <
0,025). In the control animals the relationship between RBF and
GFR was described by the equation: GFR = 0.0309 x RBF +
0.0442. In misoprostol-treated animals the actual GFR, 0.34
ml/min, was much higher than the predicted value of 0.15
mi/mm, suggesting that factors other than renal blood flow
enhancement resulted in the higher GFR in these animals.
A separate group of animals studied 24 hours after ischemia
demonstrated similar beneficial effects of prostaglandin pre-
treatment. Inulin clearance was threefold higher in misoprostol-
treated rats (Fig. 2). In addition, fractional sodium excretion
was lower (5.0 1.0 vs. 11.8 3.0%) in misoprostol-treated
animals.
Multiple preischemic doses of prostaglandin E also provided
protection against postischemic renal dysfunction. Twenty-four
hours after ischemia misoprostol-treated animals had a GFR
twice as high as control animals despite similar renal blood flow
(Table 1). However, inulin clearance in animals receiving three
preischemic doses of misoprostol was not significantly greater
than that in animals receiving a single oral dose of misoprostol
30 minutes before ischemia.
These beneficial effects of prostaglandin E pretreatment on
postischemic renal function did not appear to be due to any
antioxidant activity of the prostaglandin. As shown in Figure 3,
although renal cortical malondialdehyde content increased after
ischemia and 15 minutes of reperfusion, there was no difference
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Fig. 1. Effect of misoprostol on rena/function20 one hour after ischemia. Abbreviations are:
MAP, mean arterial pressure; inulin
10 clearance; RBF, renal blood flow; RVR, renal
vascular resistance; NS, no significant
difference. Symbols are: (D) control, N 6;0 () misoprostol, N = 6.
M
al
on
di
al
de
hy
de
, n
m
o
!/m
g 
pr
ot
 
0 
0 
0 
9 
0 
0 
b 
0 
1348 Paller and Manivel: Renal cytoprorection by prostaglandins
Fig. 2. Effect of misoprostol on renal function 24 hours after ischemia.
Abbreviation is C,,, inulin clearance. Symbols are: (L) control, N = 5;
() misoprostol, N = 6.
Table 1. Effect of multiple preischemic doses of misoprostol on
postischemic renal function
MAP
mm Hg
GFR RBF v
,uJ/minmI/mm
Control 104 3 0.26 0.08 5.4 1.4 19.9 4
(N = 6)
Misoprostol 100 4 0.55 0.08 6.5 0.7 17.4 3(N = 6)
P value NS <0.03 NS NS
Abbreviations are: MAP, mean arterial pressure; GFR, glomerular
filtration rate; RBF, renal blood flow; V, urinary flow rate; NS, no
significant difference.
between buffer-treated and misoprostol-treated postischemic
kidneys. Thus, misoprostol did not appear to limit free radical-
mediated lipid peroxidation after ischemia.
Toxic renal injury
Misoprostol was also protective against a form of toxic acute
renal failure, that caused by mercuric chloride administration.
Table 2 demonstrates the dose dependency of renal injury in
this model. Control animals receiving 2 mg/kg HgC12 had an
inulin clearance of 0.06 mllmin, whereas those that received 1.5
mg/kg had an inulin clearance of 0.35 ml/min. For each dose of
HgCI2 misoprostol resulted in a more than twofold increase in
inulin clearance. This increase in GFR by misoprostol was not
consistently accompanied by an increase in renal blood flow.
Thus, these findings are quite similar to those in renal ischemia.
Renal hypoxic injury in vitro
When primary cultures of proximal tubule epithelial cells
were subjected to 60 minutes of hypoxia and 30 minutes of
reoxygenation they suffered considerable injury. LDH release,
used as a measure of critical injury causing loss of intracellular
constituents, averaged 36.2 2.5% of total LDH with this
insult. Misoprostol prevented or greatly attenuated this injury.
Fig. 3. Lack of effect of misoprostol on free radical-mediated lipid
peroxidation after renal ischemia. Symbols are: () nonischemic, N =
6; (U) ischemia, N = 6; () misoprostol + ischemia, N = 6.
Table 2. Effect of misoprostol on HgCI2-induced renal dysfunction
MAP
mm Hg
GFR RBF v
p.1/mmmI/mm
HgCl2, 2.0 mg/kg
Control (N = 7) 118 4 0.06 0.02 0.63 0.2 3.8 1.4
Misoprostol 117 4 0.14 0.04 1.6 0.3 8.0 2.0(N =7)
P value NS <0.05 < 0.05 NS
HgCl2, 1.5 mg/kg
Control (N 8) 127 5 0.35 0.08 4.1 1.0 4.1 0.5
Misoprostol 117 5 0.81 0.14 6.0 0.8 4.2 0.9(N =5)
P value NS <0.02 NS NS
Figure 4 shows the compiled data for the six sets of studies
employing l0— to 10—6 M misoprostol. Misoprostol reduced
LDH release (injury) by 71% (P < 0.001). The dose response to
misoprostol in two sets of studies of hypoxic cell injury showed
a biphasic response (Fig. 5) with concentrations less than io—
Nt showing no beneficial effect and concentrations of i0 M
having a slightly detrimental effect. Misoprostol had no adverse
effect on LDH release in cells not subjected to hypoxia and
reoxygenation, even in concentrations of l0— M (Table 3).
The protective effects of prostaglandins in this type of acute
injury was not confined to the E class of prostaglandins.
Although misoprostol and PGE2 provided significant protection
against hypoxic renal cell injury in vitro, so too did prostacyclin
(Table 4). The effects of arachidonic acid did not reach statis-
tical significance. On the other hand, misoprostol was not
protective against injury produced by an exogenous oxidant,
such as tert-butyl hydroperoxide (Table 5).
Transmission electron microscopic evaluation was also re-
vealing. Cells studied under normoxic conditions were polar-
ized (apical microvilli, basal intermediate filaments, tight junc-
tions with interdigitation of lateral membranes) and had
intracellular organelles consistent with actively proliferating,
metabolically active cells (prominent nucleoli, endoplasmic
PcO.05
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Anoxia Anoxia +
misoprostol
Fig. 4. Effect of misoprostol on hypoxia/reoxygenation injuly of renal
tubule epithelial cells, measured as lactate dehydrogenase (LDH)
release. For this figure basal, LDH release for non-ischemic cells from
each batch of cells (range 8.5 to 28.8%) was subtracted from the
ischemic values to facilitate comparison of the data from six separate
trials.
Misoprostol, log M
Fig. 5. Dose response relationship of misoprostol protection of hy-
poxic renal tubule epithelial cells. Data was obtained from two sets of
studies each employing four cell wells for each dose of misoprostol
tested. Misoprostol 10_6 to 10—8 was significantly protective against
hypoxic renal injury (P < 0.05 vs. control by Student's t-test with
Bonferroni' s correction).
reticulum, golgi apparatus, and polyribosomes; Fig. 6). Cells
studied after hypoxia and reoxygenation in the absence of
misoprostol revealed numerous signs of both reversible and
irreversible injury. About 30% of the cells could be considered
dead, with extensive disruption of the plasma membrane,
swelling and disruption of mitochondria, disintegrating nuclei,
and cell detachment (Fig. 7). Other cells showed more limited
disruption of the apical and mitochondrial membranes, although
these changes are regarded as signs of irreversible injury (Fig.
8). All cells showed complete or nearly complete loss of apical
microvilli. Several cells had large apical membrane blebs, fluid
accumulation in the cytoplasm, and dilatation of the endoplas-
mic reticulum. In addition, they all had condensation of their
Concentration
(x lox M) LDH release %
Control (N = 7) 0 19.2 1.1
Misoprostol (N = 4) —6 13.0 0.7
Misoprostol (N 4) —4 9.3 o.8a
Control (N = 8) 0 8.5 1.2
Misoprostol (N = 8) —7 8.9 0.6
Condition LDH release %
Hypoxialreoxygenation 24.2 3.3
+ misoprostol (106 M) 4.2 1.3
+ prostacyclin (l06 M) 4.4 1.8a
+ PGE2 (10-6 M) 1.4 0.7
+ arachidonic acid (10—6 M) 11.8 3.2
To facilitate comparison of data from three separate trials, the values
for LDH release are expressed as specific LDH release (that due to
hypoxialreoxygenation), obtained by subtracting the basal LDH release
for non-hypoxic cells from each batch from the hypoxic value. The
basal LDH release ranged from 10.7 to 2 1.7% for these cells.
a P < 0.05 vs. hypoxialreoxygenation by Student's t-test with Bon-
ferroni's correction
t-butyl
hydroperoxide
mM
Duration
exposure
mm
LDH
release
%
Control cells 2 30 5.1 1.0
Misoprostol-treated 2 30 5.1 0.6
cells
Control cells 4 30 6.9 0.9
Misoprostol-treated 4 30 10.5 0.8a
cells
Control cells 2 60 21.7 1.1
Misoprostol-treated 2 60 24.5 O.6a
cells
Control cells 4 60 21.6 1.6
Misoprostol-treated 4 60 26.3 o.8
cells
Control cells 10 60 52.3 2.2
Misoprostol-treated 10 60 56.6 2.7
cells
a P < 0.05 vs. control
chromatin and multiple intracellular autophagosomes (at vari-
ous stages of development), changes reflecting reversible in-
jury. Two-thirds of the cells appeared to have lost their polarity
(loss of apical microvilli, basal intermediate filaments, and
junctions between adjacent cells). Cells treated with misopros-
tol and exposed to hypoxia and reoxygenation were quite
different in appearance. Despite hypoxia and reoxygenation
every cell had the usual quantity of microvilli, no disruption of
the apical (or basolateral) membrane, and preservation of cell
ci)
(1)
Ce
a)
a)I
-J
30
20
10
0
p.<0.001
Table 3. Effect of misoprostol on LDH release in cells not subjected
to hypoxia and reoxygenation
Cells were exposed to the indicated concentration of misoprostol for
90 minutes to determine whether the prostaglandin analogue had any
effect on basal LDH release.
a p < 0.05 vs. control
Table 4. Effect of several prostaglandins and arachidonic acid on
hypoxic tubule epithelial cell injury
a)
U)
Ce
a)
a)
=0
-J
150
100
50
0
Table 5. Lack of effect of misoprostol (106 M) on tert-butyl
hydroperoxide-induced renal tubule epithelial cell injury
0 —9 —8 —7
—6 —5 —4
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Fig. 6. Epithelial cells of proximal tubule origin cultured under normoxic conditions. Note the apical microvilli, well-developed rough
endoplasmic reticulum, numerous polyribosomes, normal mitochondria, and basal collection of intermediate filaments. Also seen are an
autophagosome (next to the nucleus) and a tight junction with a process from an adjacent cell. All cell membranes are intact. The dark material
beneath the cell is the collagen gel (uranyl acetate-lead citrate x 10,758).
polarity (Fig. 9). Nevertheless, these cells did contain numer-
ous autophagosomes, condensed chromatin, and even occa-
sional examples of mitochondrial membrane disruption.
Discussion
The ability of prostaglandins to protect against ischemic
injury of the gut, myocardium, and kidneys has been known for
several years [2—13, 16, 291. Previous studies of acute renal
injury have demonstrated a beneficial effect of prostaglandins in
some but not all studies. Moskowitz, Korobkin and Rambo
found that prostaglandin E1 increased renal blood flow, but not
GFR, when given to dogs several days after renal ischemia 121.
When Mauk and colleagues gave prostaglandin E2 by intrarenal
infusion prior to norepinephrine-induced renal ischemia, pro-
tection of GFR was noted [3]. Mundy et al and Neumayer et al
found that prostacyclin also protected against ischemic renal
injury in the dog. In the latter study the beneficial effects of
prostacyclin were felt to be secondary to renal vasodilatation
[4, 5]. Tobimatsu et at also observed protection against isch-
ernie renal dysfunction in dogs given prostaglandin E1 [6]. They
observed substantial increases in renal blood flow when pros-
taglandins were given. However, Casey et al could not demon-
strate a beneficial effect of either prostaglandin E1 or prostacy-
din on renal function in dogs subjected to renal ischemia,
although renal histology was improved by prostaglandin admin-
istration [7]. Several other investigators have also reported, in
less detail, beneficial effects of prostaglandins in renal ischemia
[8—Il]. More recently, both Lipschitz and Barnes, and Finn,
Hak and Grossman demonstrated intravenous prostacyclin to
protect against renal ischemic injury in the rat [12, 131. In
neither study was a mechanism for this protective effect found,
but Finn and coworkers suggested that a hemodynamic effect
was not likely to be the explanation because total renal blood
flow was not increased in their prostacyclin-treated animals.
Prostaglandin E also protected rats against glycerol-induced
acute renal failure, but did not protect dogs against uranyl
nitrate-induced injury [3, 14].
The present study confirms a beneficial effect of pros-
taglandin E to protect against ischemic renal injury in the rat.
The magnitude of this effect was similar to that previously
demonstrated for free radical scavengers, adenosine triphos-
phate, or mannitol. We also found protection in toxic acute
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Fig. 7. After hypoxia and reoxygenation, in the absence of misoprostol, cells show detachment, extensive disruption of plasma membranes,
swelling and disruption of mitochondria, and nuclear disintegration (uranyl acetate-lead citrate x 5943).
renal failure caused by mercuric chloride. These studies were
not designed to determine the mechanism of such an effect. The
lack of marked increases in renal blood flow might suggest that
hemodynamic factors were not primarily responsible for renal
protection. However, a beneficial redistribution of renal blood
flow or maintenance of microvascular integrity cannot be ruled
out by the in vivo studies. Furthermore, we evaluated renal
blood flow at only one time point and there was a trend towards
higher values, The strongest argument against hemodynamic
effects being solely or predominantly responsible for the bene-
ficial effects of misoprostol is the finding of protection in vitro.
Certainly hemodynamic factors could be additive to other
cytoprotective mechanisms.
The dose of misoprostol used was one we previously showed
to have no effect on GFR, renal blood flow, or solute excretion
in normal rats, although normal rats do sustain a small decrease
in blood pressure with similar doses [30]. If anything, the
hypotensive effect of misoprostol would oppose any beneficial
effects in renal ischemic injury. The present studies are also
important because a single dose of an orally active pros-
taglandin, rather than a continuous intravenous or intra-renal
infusion, was protective. The clinical relevance of this finding is
apparent, especially since misoprostol has been safely given to
patients for other indications.
The ability of prostaglandins to protect gastric mucosa
against a variety of noxious stimuli suggests a mechanism of
action involving a final common pathway for tissue injury. In a
variety of studies exogenous or endogenous prostaglandins
protected against injury caused by aspirin, ethanol, bile salts,
and hydrochloric acid [161. Prevention of gastric mucosal
barrier disruption, stimulation of mucus secretion, stimulation
of non-parietal cell alkaline secretion, enhancement of mucosal
blood flow, and preservation of microvascular integrity have
been hypothesized to be the responsible mechanism [16, 17]. At
the cellular level, stimulation of DNA and RNA synthesis,
stimulation of cellular transport processes, stimulation of cyclic
AMP formation, stabilization of tissue lysosomes, maintenance
of sulfhydryl content, and stimulation of surface-active phos-
pholipids have been postulated to produce these benefits [16,
18—20]. In ischemic myocardial tissue prostaglandins have been
clearly demonstrated to inhibit infiltration of the postischemic
muscle by neutrophils and thus limit injury [29].
In the kidney the first three possibilities suggested for gastric
mucosa protection are not applicable. Of the others, effects on
4
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Fig. S. After hypoxia and reoxygenation, in the absence of misoprostol, this cell shows less damage than those in Figure 7. Nevertheless,
disruption of the apical membrane (arrows) and mitochondrial membranes (arrowheads) are features of irreversible injury (uranyl acetate-lead
citrate x 16,394).
renal blood flow or microvascular integrity can be excluded
because prostaglandins protected against hypoxic injury in an in
vitro system. Similarly, invading neutrophils are irrelevant in
the in vitro model. Although these studies clearly demonstrate
for the first time a cytoprotective effect of prostaglandins for
renal epithelial cells, the precise mechanism for this effect in the
kidney as well as in other tissues remains unclear. These
findings do suggest that prostaglandin-mediated cytoprotection
may be a generalized phenomenon.
The histologic studies do provide clues as to the site of
protection provided by prostaglandins. Misoprostol-treated
cells had preservation of the microvilli and intact apical mem-
branes unlike control cells subjected to hypoxia and reoxygen-
ation in which these changes were extensive. Disruption of the
apical membrane, an irreversible change, was not seen in any
misoprostol-treated cell. Misoprostol-treated cells did show
many changes associated with reversible injury, including chro-
matin condensation and formation of autophagosomes. There-
fore, prostaglandins had a greater protective effect on surface
membranes than on intracellular membranes.
Both the in vivo and the in vitro studies suggest, however,
that prostaglandins do not act by preventing oxygen free radical
formation or the injurious effects of reactive oxygen species.
Although oxygen free radicals are important mediators of
ischemic injury in vivo and in vitro, they are probably not
important in mercuric chloride-induced acute renal failure [21,
26, 31]. Misoprostol protected in all of these settings. In the
present study although ischemia caused the expected increase
in free radical-mediated lipid peroxidation in the kidney, miso-
prostol did not lessen kidney lipid peroxidation [21]. Finally,
misoprostol was ineffective in preventing oxidant injury of renal
tubule epithelial cells caused by tert-butyl hydroperoxide.
Thus, in the aggregate these results exclude one potential
mechanism for prostaglandin cytoprotection.
One is tempted to further speculate as to potential mecha-
nisms of prostaglandin cytoprotection. Prostaglandin E2 stimu-
lates adenylate cyclase in the proximal tubule [32]. Cyclic AMP
could then induce protein phosphorylation via cAMP-depen-
dent protein kinase or inhibit the Na-H antiporter [33]. How-
ever, it is widely believed that prostaglandins have no direct
effect on proximal tubule ion transport [34] and there is no
evidence to support the former possibility. Finally, PGE1 has
been observed to increase membrane fluidity in synaptosomal
membrane vesicles in concentrations similar to those employed
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Fig. 9. Cell treated with misoprostol prior to exposure to hypoxia and reoxygenation. Note the preservation of apical microvilli and integrity of
membranes. Autophagosomes and chromatin condensation represent reversible injury (uranyl acetate-lead citrate x 14,710).
here (10—6 M) 35]. Although increased membrane fluidity could
enhance the activity of membrane-bound enzymes and trans-
membrane ion transporters, it is not clear how such an effect
would be protective during acute cellular injury. Thus, consid-
erable additional work will be necessary to explain this impor-
tant effect of prostaglandins on renal proximal epithelial cells.
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